OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Neoplasm Skin reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,535 reports · 56 co-occurring drugs

As of the last recalculation, Neoplasm Skin appears in 1,535 FAERS reports alongside 56 co-occurring drug terms. The strongest observed disproportionality signal is QUININE (PRR 36.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Quinine2336.937.0
Terazosin Hydrochloride2335.635.7
Clobetasol Propionate Ointment Usp, 0.05%2229.429.4
Clobetasol Propionate2229.329.3
Epoetin Alfa2225.525.6
Vemurafenib2124.024.0
Doxyclycline Hyclate2520.220.2
Captopril1419.919.9
Tofacitinib Citrate1919.919.9
Bendamustine Hcl2118.618.6
Pramipexole2017.917.9
Cyanocobalamin3816.016.0
Bendamustine Hydrochloride1416.016.0
Linagliptin2115.815.8
Felodipine Extended-Release Tablets1315.615.6
Felodipine1315.615.6
Ixazomib2813.413.4
Magnesium Oxide3812.612.6
Alendronate Sodium Tablet1712.612.6
Sulfasalazine6812.312.3
Azathioprine7612.312.3
Nebivolol1412.012.0
Cyclosporine8110.410.4
Golimumab6210.210.2
Melphalan Hydrochloride189.89.8
Infliximab1439.79.7
Propranolol Hydrochloride509.79.7
Adalimumab-Fkjp329.59.6
Selinexor69.49.4
Febuxostat Tablets 40 Mg79.49.4
Febuxostat Tablets 80 Mg79.49.4
Hydroxychloroquine499.29.2
Leflunomide668.98.9
Iron Sucrose68.68.6
Tocilizumab698.58.5
Abatacept828.48.4
Melphalan148.48.4
Febuxostat108.18.1
Ado-Trastuzumab Emtansine58.18.1
Ethyl Alcohol168.18.1
Busulfan97.87.8
Dabrafenib127.87.8
Certolizumab Pegol627.47.4
Isopropyl Alcohol176.96.9
Bortezomib436.76.7
Bleomycin Sulfate56.66.6
Icosapent Ethyl46.46.4
Siponimod46.16.1
Trametinib105.65.6
Alcohol165.65.6
Secukinumab615.35.3
Tofacitinib695.35.3
Ruxolitinib234.44.4
Apalutamide33.53.5
Lenalidomide862.92.9
Apremilast232.12.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.